Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyPeter Paschka, Clara D. Bloomfield, Guido Marcucci et al.|Journal of Clinical Oncology|2008Cited by 258
Phase <scp>II</scp> study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: <scp>DSMM XI</scp> trialHermann Einsele, Stefan Knop, Martin Kropff et al.|British Journal of Haematology|2017Cited by 30
Comparison of Clinical and Biologic Significance of WT1 Mutations in Populations of Older (≥60 years[y]) and Younger (<60 y) Adult Patients (Pts) with Cytogenetically Normal (CN) De Novo Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study.Heiko Becker, Clara D. Bloomfield, Guido Marcucci et al.|Blood|2009Cited by 25